Literature DB >> 24815749

Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression.

Catherine L Sheppard1, Louisa C Y Lee1, Elaine V Hill1, David J P Henderson1, Diana F Anthony1, Daniel M Houslay1, Krishna C Yalla1, Lynne S Cairns1, Allan J Dunlop1, George S Baillie2, Elaine Huston3, Miles D Houslay4.   

Abstract

In Rat-1 cells, the dramatic decrease in the levels of both intracellular cyclic 3'5' adenosine monophosphate (cyclic AMP; cAMP) and in the activity of cAMP-activated protein kinase A (PKA) observed in mitosis was paralleled by a profound increase in cAMP hydrolyzing phosphodiesterase-4 (PDE4) activity. The decrease in PKA activity, which occurs during mitosis, was attributable to PDE4 activation as the PDE4 selective inhibitor, rolipram, but not the phosphodiesterase-3 (PDE3) inhibitor, cilostamide, specifically ablated this cell cycle-dependent effect. PDE4 inhibition caused Rat-1 cells to move from S phase into G2/M more rapidly, to transit through G2/M more quickly and to remain in G1 for a longer period. Inhibition of PDE3 elicited no observable effects on cell cycle dynamics. Selective immunopurification of each of the four PDE4 sub-families identified PDE4D as being selectively activated in mitosis. Subsequent analysis uncovered PDE4D9, an isoform whose expression can be regulated by Disrupted-In-Schizophrenia 1 (DISC1)/activating transcription factor 4 (ATF4) complex, as the sole PDE4 species activated during mitosis in Rat-1 cells. PDE4D9 becomes activated in mitosis through dual phosphorylation at Ser585 and Ser245, involving the combined action of ERK and an unidentified 'switch' kinase that has previously been shown to be activated by H2O2. Additionally, in mitosis, PDE4D9 also becomes phosphorylated at Ser67 and Ser81, through the action of MK2 (MAPKAPK2) and AMP kinase (AMPK), respectively. The multisite phosphorylation of PDE4D9 by all four of these protein kinases leads to decreased mobility (band-shift) of PDE4D9 on SDS-PAGE. PDE4D9 is predominantly concentrated in the perinuclear region of Rat-1 cells but with a fraction distributed asymmetrically at the cell margins. Our investigations demonstrate that the diminished levels of cAMP and PKA activity that characterise mitosis are due to enhanced cAMP degradation by PDE4D9. PDE4D9, was found to locate primarily not only in the perinuclear region of Rat-1 cells but also at the cell margins. We propose that the sequestration of PDE4D9 in a specific complex together with AMPK, ERK, MK2 and the H2O2-activatable 'switch' kinase allows for its selective multi-site phosphorylation, activation and regulation in mitosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; DISC1; MK2; Mitosis; PDE4; PDE4D9

Mesh:

Substances:

Year:  2014        PMID: 24815749     DOI: 10.1016/j.cellsig.2014.04.023

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  11 in total

1.  The spatio-temporal dynamics of PKA activity profile during mitosis and its correlation to chromosome segregation.

Authors:  Pauline Vandame; Corentin Spriet; Dave Trinel; Armance Gelaude; Katia Caillau; Coralie Bompard; Emanuele Biondi; Jean-François Bodart
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.

Authors:  Li Wang; Brian T Burmeister; Keven R Johnson; George S Baillie; Andrei V Karginov; Randal A Skidgel; John P O'Bryan; Graeme K Carnegie
Journal:  Cell Signal       Date:  2015-02-12       Impact factor: 4.315

3.  RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2015-08-06       Impact factor: 4.315

4.  Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains.

Authors:  Graeme B Bolger; Allan J Dunlop; Dong Meng; Jon P Day; Enno Klussmann; George S Baillie; David R Adams; Miles D Houslay
Journal:  Cell Signal       Date:  2014-12-27       Impact factor: 4.315

Review 5.  Scaffolding during the cell cycle by A-kinase anchoring proteins.

Authors:  B Han; W J Poppinga; M Schmidt
Journal:  Pflugers Arch       Date:  2015-07-24       Impact factor: 3.657

6.  Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners.

Authors:  Kirsty F Houslay; Frank Christian; Ruth MacLeod; David R Adams; Miles D Houslay; George S Baillie
Journal:  Biochem J       Date:  2016-12-19       Impact factor: 3.857

7.  Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression.

Authors:  R Böttcher; D J P Henderson; K Dulla; D van Strijp; L F Waanders; G Tevz; M L Lehman; D Merkle; G J L H van Leenders; G S Baillie; G Jenster; M D Houslay; R Hoffmann
Journal:  Br J Cancer       Date:  2015-11-17       Impact factor: 7.640

8.  MEK Inhibitors Reverse cAMP-Mediated Anxiety in Zebrafish.

Authors:  Pia R Lundegaard; Corina Anastasaki; Nicola J Grant; Rowland R Sillito; Judith Zich; Zhiqiang Zeng; Karthika Paranthaman; Anders Peter Larsen; J Douglas Armstrong; David J Porteous; E Elizabeth Patton
Journal:  Chem Biol       Date:  2015-09-17

9.  AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.

Authors:  M Johanns; Y-C Lai; M-F Hsu; R Jacobs; D Vertommen; J Van Sande; J E Dumont; A Woods; D Carling; L Hue; B Viollet; M Foretz; M H Rider
Journal:  Nat Commun       Date:  2016-03-08       Impact factor: 14.919

10.  Phenotypic Variability in a Family with Acrodysostosis Type 2 Caused by a Novel PDE4D Mutation Affecting the Serine Target of Protein Kinase-A Phosphorylation.

Authors:  Julia Hoppmann; Julia Gesing; Caroline Silve; Chrystel Leroy; Astrid Bertsche; Franz Wolfgang Hirsch; Wieland Kiess; Roland Pfäffle; Volker Schuster
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.